Evidence map›Paper›PMID 23702176›Full record

ReviewClinics in chest medicine2013

Human immunodeficiency virus-associated obstructive lung diseases.

Matthew R Gingo, Alison Morris, Kristina Crothers

Abstract readReview
In one paragraph

Review in Clinics in chest medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Review
  3. HIV-associated lung disease.Nature reviews. Disease primers · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Long-term pulmonary complications in perinatally HIV-infected youth.The Journal of allergy and clinical immunology · 2017
    Article
  13. The epidemiology of noncommunicable respiratory disease in sub-Saharan Africa, the Middle East, and North Africa.Malawi medical journal : the journal of Medical Association of Malawi · 2017
    Review
  14. Article
  15. HIV infection model of chronic obstructive pulmonary disease in mice.American journal of physiology. Lung cellular and molecular physiology · 2017
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Matthew R GingoDivision of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
Alison Morris
Kristina Crothers

Funding

Longitudinal Studies of HIV-Associated Lung Infections and ComplicationsR01HL090342 · NHLBI · YALE UNIVERSITY · PI CROTHERS, KRISTINA ANNE · 2007 to 2011
$4.0M
Prevalence & Pathogenesis of Pulmonary Disease in a Large Multicenter HIV CohortR01HL090339 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MORRIS, ALISON · 2007 to 2011
$4.0M
Pneumocystis in Pathogenesis of HIV-associated EmphysemaR01HL083461 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MORRIS, ALISON · 2005 to 2009
$2.2M
HIV infection and AsthmaK23HL108697 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GINGO, MATTHEW R. · 2011 to 2015
$662k
IMMUNE COMPETENCE OF HUMAN PLEURAL MESOTHELIAL CELLSF32HL008346 · NHLBI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CAMP, MARK A · 1991 to 1991
–
NHLBI NIH HHS HL083461SNHLBI NIH HHS K23 HL108697NHLBI NIH HHS R01 HL083461NHLBI NIH HHS R01 HL 090339NHLBI NIH HHS R01 HL090339NHLBI NIH HHS R01 HL 090342NHLBI NIH HHS R01 HL090342
6 · The paper itself

Abstract

In the era of effective antiretroviral therapy (ART), epidemiologic studies have found that persons infected with human immunodeficiency virus (HIV) have a higher prevalence and incidence of chronic obstructive pulmonary disease than HIV-uninfected persons. In comparison with HIV-uninfected persons and those with well-controlled HIV disease, HIV-infected persons with poor viral control or lower CD4 cell count have more airflow obstruction, a greater decline in lung function, and possibly more severe diffusing impairment. This article reviews the evidence linking HIV infection to obstructive lung disease, and discusses management issues related to the treatment of obstructive lung disease in HIV-infected patients.

Indexed as

AsthmaCD4 Lymphocyte CountHIV InfectionsHumansPulmonary Disease, Chronic ObstructiveRisk FactorsSmoking

Identifiers

PMID23702176
PMCPMC3690924

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.